CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Apr. 01, 2016		Apr. 03, 2015
Cash flows from operating activities:
Net earnings	$ 186,025		$ 199,283
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	23,805		25,238
Tax benefits from exercises of share-based payment awards	821		11,144
Excess tax benefits from share-based compensation	(1,579)		(11,138)
Depreciation	31,127		30,111
Amortization of intangible assets	6,801		3,286
Deferred taxes	644		16,399
Provision for doubtful accounts receivable	3,645		6,682
Other, net	(73)		1,514
Changes in assets and liabilities:
Accounts receivable	(94,471)		(17,457)
Inventories	(39,652)		(92,951)
Prepaid expenses and other assets	(15,669)		(20,987)
Accounts payable	(13,637)		(12,833)
Accrued liabilities and other long-term liabilities	1,835		(43,159)
Deferred revenues and advance payments from customers	19,505		37,134
Net cash provided by operating activities	109,127		132,266
Cash flows from investing activities:
Purchases of property, plant and equipment	(45,938)		(36,722)
Decrease (increase) in restricted cash	572		(35,710)
Sale of available-for-sale securities	8,638		0
Notes receivable	(6,159)		(5,000)
Net amounts received from (paid to) deferred compensation plan trust account	(2,907)		3,102
Other	(732)		(838)
Net cash used in investing activities	(46,526)		(75,168)
Cash flows from financing activities:
Repurchases of common stock	(248,704)		(201,181)
Proceeds from issuance of common stock to employees	21,210		67,221
Excess tax benefits from share-based compensation	1,579		11,138
Employees' taxes withheld and paid for restricted stock and restricted stock units	(10,715)		(16,046)
Borrowings under credit facility agreement	83,000		0
Repayments under credit facility agreement	(108,000)		(25,000)
Net borrowings under credit facility agreements with maturities less than 90 days	322,000		100,000
Contingent consideration and hold back	(3,710)		(1,070)
Other	496		1,774
Net cash provided by (used in) financing activities	57,156		(63,164)
Effects of exchange rate changes on cash and cash equivalents	(4,125)		19,014
Net increase in cash and cash equivalents	115,632		12,948
Cash and cash equivalents at beginning of period	845,468	[1]	849,275
Cash and cash equivalents at end of period	$ 961,100		$ 862,223

[1] The condensed consolidated balance sheet as of October 2, 2015 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.